Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Impact of Lofexidine on Stress, Craving and Opioid Use

Trial Profile

Impact of Lofexidine on Stress, Craving and Opioid Use

Status: Recruiting
Phase of Trial: Phase II

Latest Information Update: 04 Jul 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Lofexidine (Primary)
  • Indications Opioid abuse
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Jul 2019 Status changed from not yet recruiting to recruiting.
    • 04 Jun 2019 Planned initiation date changed from 1 Jun 2019 to 11 Jun 2019.
    • 15 Apr 2019 Planned initiation date changed from 2 Apr 2019 to 1 Jun 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top